Barclays Adjusts Price Target on Centene to $90 From $104, Maintains Overweight Rating
Navigating 11 Analyst Ratings For Centene
Oppenheimer Reiterates Outperform on Centene, Maintains $110 Price Target
Centene Analyst Ratings
Centene Analyst Ratings
Cantor Fitzgerald Reiterates Overweight on Centene, Maintains $90 Price Target
Centene Corp: Stephens cuts target price from $83 to $77
Stephens Adjusts Price Target on Centene to $77 From $83
Centene Analyst Ratings
What 11 Analyst Ratings Have To Say About Centene
Oppenheimer Remains a Buy on Centene (CNC)
Analysts Offer Insights on Healthcare Companies: Centene (CNC), Zimmer Biomet Holdings (ZBH) and Madrigal Pharmaceuticals (MDGL)
Centene Analyst Ratings
Centene Analyst Ratings
Barclays Adjusts Price Target on Centene to $104 From $101
Deutsche Bank: Maintaining the Centene (CNC.US) rating, adjusted from holding to holding rating, and adjusted the target price from $81.00 to $82.00.
Centene Analyst Ratings
Deutsche Bank Maintains Hold on Centene, Raises Price Target to $82
Jefferies Adjusts Price Target on Centene to $90 From $94
Oppenheimer: Maintaining the Centene (CNC.US) rating, adjusted from superior to superior market rating, and adjusted the target price from $110.00 to $110.00.